Carolos Cordon-Cardo

Title: The Innovations of Carolos Cordon-Cardo

Introduction

Carolos Cordon-Cardo is a prominent inventor based in New York, NY (US). He is known for his significant contributions to the field of cancer research, particularly through his innovative work on monoclonal antibodies.

Latest Patents

Cordon-Cardo holds a patent for "Monoclonal antibodies to cell surface antigens of human teratocarcinomas." This patent describes antibody-producing hybridoma cell lines created by fusing NS/1 cells with spleen cells of mice that have been immunized with human teratocarcinoma cells. The monoclonal antibodies derived from these cell lines are capable of recognizing the K4, K2, and P12 antigenic systems. These antibodies are instrumental in detecting and differentiating between normal and cancerous cells, making them particularly valuable in the pathological analysis of human tumors, especially teratocarcinomas.

Career Highlights

Cordon-Cardo is affiliated with the Sloan-Kettering Institute for Cancer Research, where he has made significant strides in cancer diagnostics and treatment. His work has been pivotal in advancing the understanding of cancer biology and improving therapeutic strategies.

Collaborations

Some of his notable coworkers include Wolfgang J. Rettig and Herbert F. Oettgen. Their collaborative efforts have contributed to the advancement of cancer research and the development of innovative diagnostic tools.

Conclusion

Carolos Cordon-Cardo's contributions to the field of cancer research through his patent on monoclonal antibodies exemplify the impact of innovation in medical science. His work continues to influence the diagnosis and treatment of cancer, showcasing the importance of research and collaboration in advancing healthcare.